The RAPID - PE Study: RESCUE Advanced Protocol for the Treatment of Pulmonary Embolism
Not Applicable
Not yet recruiting
- Conditions
- Pulmonary Embolism
- Interventions
- Device: The Bashirâ„¢ Endovascular CatheterDrug: r-tPA
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- Thrombolex, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT06433011
tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden
Phase 3
Completed
- Conditions
- Pulmonary Embolism
- Interventions
- Device: The Bashirâ„¢ Endovascular CatheterDrug: r-tPA
- First Posted Date
- 2020-01-30
- Last Posted Date
- 2023-04-20
- Lead Sponsor
- Thrombolex, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT04248868
- Locations
- 🇺🇸
Mt Carmel, Columbus, Ohio, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸Emory, Atlanta, Georgia, United States
First - In - Man Study to Assess the Safety and Feasibility of The Bashirâ„¢ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism
Phase 1
Completed
- Conditions
- Pulmonary Embolism
- Interventions
- Drug: r-tPADevice: The Bashirâ„¢ Endovascular Catheter
- First Posted Date
- 2019-04-25
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- Thrombolex, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03927508
- Locations
- 🇺🇸
St Vincent Hospital and Health Care Center, Inc., Indianapolis, Indiana, United States
🇺🇸Columbia University Medical Center - Presbyterian - New York, New York, New York, United States
🇺🇸Advent Health Orlando, Orlando, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath